Validation analysis of a composite real‐world mortality endpoint for patients with cancer in the United States

Real-world evidence and regulatory drug approval

(2020) Michael J. Raphael et al.   Nature Reviews Clinical Oncology

Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence

(2020) Richard E. Gliklich et al.   Therapeutic Innovation & Regulatory Science

Use of real-world data for new drug applications and line extensions

(2020) Winona R. Bolislis et al.   CLINICAL THERAPEUTICS

An evaluation of the impact of missing deaths on overall survival analyses of advanced non–small cell lung cancer patients conducted in an electronic health records database

(2019) Gillis Carrigan et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database

(2019) Gaurav Singal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ghost-time Bias from Imperfect Mortality Ascertainment in Aging Cohorts

(2018) Eric J. Jacobs et al.   ANNALS OF EPIDEMIOLOGY

Development and Validation of a High-Quality Composite Real-World Mortality Endpoint

(2018) Melissa D. Curtis et al.   HEALTH SERVICES RESEARCH

Consequences for Healthcare Quality and Research of the Exclusion of Records From the Death Master File

(2013) Briget da Graca et al.  

Missing Data in Clinical Studies: Issues and Methods

(2012) Joseph G. Ibrahim et al.   JOURNAL OF CLINICAL ONCOLOGY

Sensitivity analysis for multiple right censoring processes: Investigating mortality in psoriatic arthritis

(2010) Fotios Siannis   STATISTICS IN MEDICINE